Héloïse Bleton currently serves as the Head of Engineering - Diagnostics at Owkin, where management of the Software Development Team in the Diagnostics Department is a key responsibility. Prior experience includes roles at Echosens, where Héloïse progressed from Software Project Manager to Software Engineering Manager, overseeing a team of 20 and introducing crucial cybersecurity measures and development workflows. Héloïse has also worked at Air Liquide as a Technical Lead and R&D Engineer, leading the development of hardware and software solutions for medical devices. Academic foundations include a Master of Science in Electrical, Electronics and Communications Engineering from INSA Lyon and another Master of Science from the University of Pittsburgh, complemented by roles in research and teaching.
Upgrade to view 0 reports
This person is not in any teams
This person is not in any offices
Owkin
4 followers
Owkin believes that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is pioneering AI in healthcare. It leverages its collaborative federated learning software and expert AI capabilities to bring solutions to optimize drug development and improve patient care in oncology. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $70M from leading VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Additionally, Owkin leads several federated learning consortia, including; MELLODDY, to facilitate 'co-opetive' drug discovery between pharma companies, and Healthchain, to allow collaborative research across multiple hospitals. Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, Ph.D., an academic pioneer in the field of Artificial Intelligence in biology.